CDO1酸化是IL-6诱导的瘤细胞增殖所需的,通过控制囊氨酸的可用性来控制
Xin Li1, Zhe Zhao2, Hongping Ye1
1State Key Laboratory of Oral Diseases & National Center for Stomatology & National Clinical Research Center for Oral Diseases & Chinese Academy of Medical Sciences Research Unit of Oral Carcinogenesis and Management, Department of Oral Medicine, West China Hospital of Stomatology, Sichuan University, Chengdu, Sichuan, 610041, China.
Cell communication and signaling : CCS
|April 24, 2025
概括
洲际蛋白-6 (IL-6) 通过酸化氨酸二氧化酶1型 (CDO1) 抑制氨酸氧化,促进口腔状细胞癌 (OSCC) 的生长. 这种由AKT1介导的机制为OSCC提供了潜在的抗瘤标.
科学领域:
- 生物化学 生物化学
- 癌症生物学 癌症生物学
- 分子瘤学分子瘤学
背景情况:
- 癌细胞利用炎症途径进行增殖和生存.
- 氨酸二氧化酶1型 (CDO1) 通过催化氨酸氧化来调节氨酸的可用性.
- 炎症对CDO1活性的影响及其在瘤生长中的作用尚不清楚.
研究的目的:
- 调查炎症环境如何影响CDO1活性和囊氧化.
- 阐明连接炎症,CDO1和口腔状细胞癌 (OSCC) 增长的机制.
- 在这个途径中识别潜在的抗瘤点.
主要方法:
- 用Interleukin-6 (IL-6) 对细胞进行治疗.
- 评估CDO1表达和酶活性.
- 在T89通过AKT1.1.进行CDO1酸化的分析.
- AKT1介导的CDO1酸化与OSCC生长和进展的相关性.
主要成果:
- IL-6治疗抑制了CDO1活性和囊蛋白氧化,但没有改变CDO1的表达.
- 在IL-6刺激下,AKT1在T89处化CDO1,通过破坏铁的结合抑制其酶活性.
- AKT1介导的CDO1 T89酸化对IL-6诱导的OSCC生长至关重要.
- 这种酸化与OSCC的进展有关.
结论:
- 一个新的机制揭示了AKT1介导的CDO1 T89酸化抑制了囊氧化,支持OSCC的生长.
- 这一途径代表了OSCC中抗瘤策略的潜在治疗标.
相关概念视频
mTOR Signaling and Cancer Progression
3.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.6K
Inhibition of Cdk Activity
4.6K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.6K
Abnormal Proliferation
4.3K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.3K
The JAK-STAT Signaling Pathway
8.4K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.4K
PI3K/mTOR/AKT Signaling Pathway
3.3K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.3K
Mitogens and the Cell Cycle
6.3K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.3K


